[1] Larcher A, Laulin JP, Celerier E, et al. Acute tolerance associated with a single opiate administration: involvement of N-aspartate-dependent pain facilita to rusystems [J]. Neur oscience, 1998, 84(2): 583-589. [2] 杜金, 黄宇光, 罗爱伦. 普瑞巴林对大鼠慢性炎性疼痛治疗过程中吗啡急性耐受的抑制作用[J]. 中国临床药理学与治疗学, 2008, 13(11): 1249-1253. [3] Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoper ative remifentanil increases postoperative pain and morphine requirement [J]. Anesthe siology, 2000, 93(2): 409-417. [4] Boyce S, Wyatt A, Webb JK, et al. Selective NMDA NR2B a ntagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn[J]. Neuro pharmacology, 1999, 38(5): 611-623. [5] Xuerong Y, Yuguang Huang, XJ, et al. Ketamine and lornoxicam on preventing fentanyl-induced increase in postoper ative morphine requirement[J]. Anesth Analg, 2008, 107(6): 2032-2037. [6] Kissin I, Bright CA, Bradley EL Jr. Can inflammatory pain prevent the development of acute tolerance to alfentanil[J] ? Anesth Analg, 2001, 92(5): 1296-1300. [7] Millan M J. The induction of pain: aninteg rativereview[J]. Prog Neurobio l, 1999, 57(1): 1-164. [8] Laulin JP, Maurette P, Corcuff JB, et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance[J]. Anesth Analg, 2002, 94(5): 1263-1269. [9] Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes[J]. Pain, 1999, 82(2): 111-125. [10] Kissin I. Preemptive analgesia[J]. Anesthesiology, 2000, 93(4): 1138-1143. [11] Inoue M, Mishina M, Ueda H. Locus-specific rescue of GluRepsilon 1 NMDA receptor s in mutant mice identifies the brain regions important for morphine to lerance and dependence [J]. J Neurosce, 2003, 23(16): 6529-6536. [12] Sigg ns GR, Mar tin G, Roberto M, et al. Glutamatergictrans mission in o piate and alcohol dependence[J]. Ann NY Acad Sci, 2003, 1003:196-211. [13] Lim G, Wang S, Zeng Q, et al. Expression of spinal NMDA receptor and PKC gamma after chronic morphine is regulated by spinal glucocorticoid receptor[J]. J Neur osce, 2005, 25(48): 11145-11154. [14] Zhu H, Ja ng CG, Ma T, et al. Region specific expression of NMDA receptorNR1 subunit mRNA in hypthalamus and pons following chronic morphine treatment[J]. Eur J Pharmaco l, 1999, 365(1): 47-54. [15] Bajo M, Cr awfo rd EF, Rober to M, et al. Chronicmo rphinet reatment alters expression of N-Me thy l-D-Aspartate receptor subunits in the extended amygdala[J]. J Neur o Res, 2006, 83(4): 532-537. [16] Mar tin G, Guadano-Ferraz A, Morte B, et al. Chronic morphine t reatmentalters N-methyl-D-aspartate receptors in freshly isola ed neurons from nucleus accumbens[J]. J Pharmaco l Exp Ther, 2004, 311(1): 265-273. [17] Mar tin G, Ahmed SH, Blank T, et al. Chronicmorphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens[J]. J Neurosci, 1999, 19(20): 9081-9089. [18] Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain[J]. Clin J Pain,2000, 16(2 Suppl): S73-S79. [20] Chizh BA. NMDA receptor ranagonists as analgesics: focus on the NR2B subtype[J]. T rends Pharmacol Sci, 2001, 22(12): 636-642. |